Roche CEO Severin Schwan said the company expects its current pipeline to provide growth in the long term, as reported NASDAQ Friday.
The news comes as Roche has faced scrutiny from the US over its planned $4.3-billion takeover of Spark Therapeutics.
"I feel confident that we have a strong pipeline that would support growth in the longer term," said Schwan.
"I don't think it's a wise strategy in the long term to fill a growth gap by M&A," the CEO remarked, adding "if you start filling gaps, you run the risk that you overpay or you take on board assets which do not fit strategically."
Schwan indicated that Roche now expects to complete the Spark deal by the end of the year.
To read more NewsPoints articles, click here.